bf/NASDAQ:IONS_icon.jpeg

NASDAQ:IONS

Ionis Pharmaceuticals, Inc.

  • Stock

USD

Last Close

44.66

28/03 17:58

Market Cap

7.39B

Beta: 0.54

Volume Today

1.22M

Avg: 904.55K

PE Ratio

−17.34

PFCF: −15.39

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Select
  • website

    www.ionispharma.com
  • ipo date

    May 17, 1991
  • full time employees

    796
  • currency

    USD

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis...Show More

Earnings

Earnings per Share (Estimate*)

-2-1122015-05-052017-05-092019-05-092021-05-052023-05-03

Revenue (Estimate*)

1B2B3B4B2015-05-052017-05-092019-05-092021-05-052023-05-03

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.